Skip to main content

Table 1 Clinical characteristics of patients according to oral glucose tolerance test groups

From: Glucose tolerance status is a better predictor of diabetes and cardiovascular outcomes than metabolic syndrome: a prospective cohort study

 

Normal (n = 43)

IFG£(n = 42)

IGT£(n = 38)

DM£(n = 25)

P

Age (years)

59 ± 12

61 ± 13

61 ± 11

64 ± 11

0.50

Men – n (%)

21 (49)

17 (41)

10 (26)

9 (36)

0.22

White – n (%)

27 (63)

29 (69)

25 (66)

18 (72)

0.64

Smoking - n (%)

10 (23)

6 (14)

2 (5)

3 (12)

0.12

Hypertension - n (%)

20 (47)*

30 (73)

22 (58)

22 (88)*

0.003

Systolic BP § (mmHg)

135 ± 23

146 ± 25

137 ± 17

146 ± 19

0.055

Diastolic BP § (mmHg)

83 ± 13

87 ± 13

87 ± 10

89 ± 10

0.12

Family History of DM - n (%)

10 (23)

8 (19)

9 (24)

5 (20)

0.91

Sedentary – n (%)

20 (47)

24 (57)

26 (68)

16 (64)

0.48

Cardiovascular Risk score ǂ

8 (5–15)

9 (3–13)

6 (2–12)

10 (2–15)

0,41

BMI (kg/m2)

25.7 ± 2.5*

29.6 ± 4.6

31.2 ± 5.7*

29.2 ± 5.1

0.019

Waist Circumference (cm)

     

Men

98.1 ± 8.2

103.0 ± 8.2

97.6 ± 7.7

98.3 ± 3.9

0.36

Women

94.4 ± 11.9

96.6 ± 8.6

100.6 ± 9.4

102.0 ± 12.2

0.23

  1. Data expressed in mean ± standard deviation, number of cases (%) and median (interquartile interval).
  2. £Oral glucose tolerance test groups: IFG impaired fasting glucose, IGT impaired glucose tolerance, DM diabetes mellitus.
  3. §BP blood pressure, BMI body mass index, ǂ Framingham Score: cardiovascular risk in ten years.
  4. *Difference between groups.